Results 211 to 220 of about 274,619 (381)

Mechanism of Plasma Iron Incorporation into Hepatic Ferritin

open access: hybrid, 1960
Abraham Mazur, Saul Green, Anne Carleton
openalex   +1 more source

Registries on transcatheter edge‐to‐edge repair in heart failure: Current evidence and future perspectives

open access: yesEuropean Journal of Heart Failure, EarlyView.
Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese   +13 more
wiley   +1 more source

The organ-specificity of ferritin in human and horse liver and spleen [PDF]

open access: green, 1973
Robert R. Crichton   +3 more
openalex   +1 more source

Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Differences in baseline characteristics between major trials of intravenous (IV) iron therapy in heart failure. LVEF, left ventricular ejection fraction; SGLT2, sodium–glucose cotransporter 2. Aims Prior randomized trials have reported conflicting evidence regarding the efficacy of intravenous (IV) iron in patients with heart failure with reduced ...
Stefan D. Anker   +44 more
wiley   +1 more source

Ferritin, cellular iron storage and regulation

open access: yesIUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology, 2017
P. Arosio, L. Elia, Maura Poli
semanticscholar   +1 more source

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura   +23 more
wiley   +1 more source

Non-carcinogenicity of cadmium-free ferritin

open access: green, 1968
F. J. C. Roe   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy